Search

everythinglearnresearchcommunity

for

Search:↓

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Nutrient antioxidants helped reduce prednisolone dosage and improved hair growth in alopecia areata patients.

The F2 Emulgel with Tridax procumbens extract showed the best qualities for healing wounds.

The F2 Emulgel with Tridax procumbens extract showed good physical properties and antimicrobial effectiveness for wound healing.

Two young cats with a severe ear and skin condition improved with immune system-targeting treatments.

Melatonin may help reduce the needed dose of prednisolone and improve hair growth in alopecia areata patients.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Type-2 immunity may influence skin diseases and could be targeted for treatment.